Cresta 20 MUPS Tablet Mups Tablet

Cresta 20 MUPS Tablet সম্পর্কে

Cresta 20 MUPS Tablet হলো Rabeprazole Sodium-এর একটি ব্র্যান্ড, শক্তি ২০ mg, Mups Tablet আকারে। Rabeprazole Sodium-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এটি তৈরি করে Advanced Chemical Industries PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Rabeprazole Sodium-এর ৪৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Acifix 10 mg Sprinkle Capsule-এর, প্রতি ইউনিট ৳ ৩.৫০।

Cresta 20 MUPS Tablet কী?

Cresta 20 MUPS Tablet is a medicine that reduces the amount of acid your stomach produces. It contains rabeprazole sodium, which belongs to a group called proton pump inhibitors. Doctors prescribe it for adults with active duodenal or gastric ulcers, and for gastro-oesophageal reflux disease, where stomach acid flows back into the food pipe. It can also be used for long-term management of reflux. The tablet is a MUPS (multi-unit pellet system) form, which may make it easier to swallow. Always follow your doctor's instructions about how to take it.

Cresta 20 MUPS Tablet-এর ব্যবহার

Cresta 20 MUPS Tablet is used to treat active duodenal ulcers and active benign gastric ulcers. It is also used for symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GERD), for long-term management of GERD, and for moderate to very severe GERD. Your doctor will decide if this medicine is right for your condition and how long you should take it.

Cresta 20 MUPS Tablet কীভাবে ব্যবহার করবেন

Take Cresta 20 MUPS Tablet exactly as your doctor tells you. The tablet is usually taken by mouth. Your doctor will decide the dose and how long you need to take it. Do not change the dose or stop the medicine without asking your doctor first. If you have trouble swallowing tablets, ask your pharmacist whether this MUPS tablet can be taken in a different way. Keep all appointments so your doctor can check your progress.

Cresta 20 MUPS Tablet-এর পার্শ্বপ্রতিক্রিয়া

Like all medicines, Cresta 20 MUPS Tablet can cause side effects, though not everyone gets them. Common ones include headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, and dizziness. These are usually mild. Call your doctor if you notice any side effect that bothers you or does not go away. Seek urgent medical help if you have a serious reaction such as swelling of the face or throat, or severe skin rash.

সতর্কতা ও নিরাপত্তা

Cresta 20 MUPS Tablet is not suitable for everyone. Do not take it if you are allergic to rabeprazole or any of its ingredients. It is contraindicated in pregnancy and during breastfeeding. Tell your doctor if you are pregnant, planning a pregnancy, or breastfeeding. Before starting treatment, your doctor should rule out stomach or oesophageal cancer, because this medicine can relieve symptoms without curing cancer. If you take long-term treatment, especially for more than a year, you should be monitored regularly. Proton pump inhibitors may modestly increase the risk of hip, wrist and spine fractures, particularly in the elderly or those with other risk factors. Tell your doctor about all other medicines you take, especially ketoconazole, itraconazole or atazanavir.

সাধারণ প্রশ্ন

What is Cresta 20 MUPS Tablet used for and what kind of medicine is it?

It is a proton pump inhibitor containing rabeprazole sodium. It reduces stomach acid and is used for active duodenal ulcers, active benign gastric ulcers, and gastro-oesophageal reflux disease (GERD), including long-term management. Your doctor will decide if it is suitable for you.

How should I store Cresta 20 MUPS Tablet?

Keep the tablets below 30°C, away from light and moisture. Store them out of the reach of children. Do not use after the expiry date printed on the pack. If you are unsure, ask your pharmacist.

What side effects should I watch for and when should I call my doctor?

Watch for headache, diarrhoea, stomach pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, or dizziness. Call your doctor if any side effect bothers you or does not go away. Seek urgent help for serious reactions like swelling of the face or throat, or severe skin rash.

Can I take Cresta 20 MUPS Tablet with other medicines?

Some medicines can interact with rabeprazole, including ketoconazole, itraconazole, and atazanavir. Tell your doctor or pharmacist about all medicines you take, including ones bought without a prescription, so they can check for interactions and advise you.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rabeprazole Gastro-resistant tablets are indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • ... Read more
Rabeprazole Gastro-resistant tablets are indicated for the treatment of:
  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD).
  • Gastro-esophageal Reflux Disease Long-term Management (GERD Maintenance)
  • Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Active Duodenal Ulcer and Active Benign Gastric Ulcer: The recommended oral dose for both bioactive duodenal ulcer and active benign gastric ulcer is 20 mg to be taken once daily in the morning. Most patients with active duodenal ulcer heal within four weeks. However, a few patients may require an additional four weeks of therapy to achieve healing. Most patients with active benign gastric ulcer heal within six weeks. However, again a few patients may require an additional six weeks of therapy to achieve healing.

Erosive or Ulcerative Gastro-Esophageal Reflux Disease (GERD): The recommended oral dose for this condition is 20 mg to be taken once daily for four to eight weeks.

Gastro-Esophageal Reflux Disease Long-term Management (GERD Maintenance): For long-term management, a maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily can be used depending upon patient response.

Symptomatic treatment of moderate to very severe Gastro-Esophageal Reflux Disease (symptomatic GERD): 10 mg once daily in patients without oesophagitis. If symptom control has not been achieved during four weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on-demand regimen taking 10 mg once daily when needed.

Treatment of GERD in pediatric patients 1 to 11 years of age (Less than 15 kg): 5 mg once daily for 12 weeks with the option to increase to 10 mg if inadequate response.

Treatment of GERD in pediatric patients 1 to 11 years of age (15 kg or more): 10 mg once daily for 12 weeks. 

Zollinger-Ellison Syndrome: The recommended adult starting dose is 60 mg once a day. The dose may be titrated upwards to 120 mg/day based on individual patient needs. Single daily doses up to 100 mg/day may be given. 120 mg dose may require divided doses, 60 mg twice daily. Treatment should continue for as long as clinically indicated.

Eradication of H. pylori: Patients with H. pylori infection should be treated with eradication therapy. The following combination given for 7 days is recommended. Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily and amoxicillin 1g twice daily.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Respite produces a profound and long-lasting inhibition of gastric acid secretion. An interaction with a compound whose absorption is pH dependent may occur. Co-administration of rabeprazole sodium with ketoconazole or itraconazole may result in a significant decrease in antifungal plasma levels. Therefore individual patients may need to be monitored to determine if a dosage adjustment is necessary when ketoconazole or itraconazole are taken concomitantly with Respite. No interaction with liquid antacids was observed. The absorption of atazanavir is pH-dependent. Therefore PPIs, including rabeprazole, should not be co-administered with atazanavir.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity to the active substance or to any of the excipients. Rabeprazole is contra-indicated in pregnancy and during breastfeeding.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

In general, Rabeprazole is well-tolerated in both short-term and long-term studies. Rabeprazole may sometimes cause headache, diarrhoea, abdominal pain, vomiting, constipation, dry mouth, increased or decreased appetite, muscle pain, drowsiness, dizziness.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

US FDA pregnancy category 'C'. Studies have been performed in animals and have revealed no evidence of impaired fertility or harm to the fetus due to Rabeprazole. There are however, no adequate and well-controlled studies in pregnant women. Rabeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Symptomatic response to therapy with Rabeprazole does not preclude the presence of gastric or oesophageal malignancy, therefore the possibility of malignancy should be excluded prior to commencing treatment with Rabeprazole 20 mg Gastro-resistant Tablets.
  • Patients on long-term treatment (particularly those treated for more than a year) should be kept under regular surveillance.
  • Proton pump inhibitors, especially if used in high doses and over long durations (>1 year), may modestly increase the risk of hip, wrist and spine fracture, predominantly in the elderly or in presence of other recognised risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10–40%. Some of this increase may be due to other risk factors. Patients at risk of osteoporosis should receive care and they should have an adequate intake of vitamin D and calcium.
  • A risk of cross-hypersensitivity reactions with other proton pump inhibitor or substituted benzimidazoles cannot be excluded.
  • Patients should be cautioned that Rabeprazole gastro-resistant tablets should not be chewed or crushed, but should be swallowed whole.
  • There have been post marketing reports of blood dyscrasias (thrombocytopenia and neutropenia). In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
  • Hepatic enzyme abnormalities have been seen in clinical trials and have also been reported since market authorisation. In the majority of cases where an alternative aetiology cannot be identified, the events were uncomplicated and resolved on discontinuation of rabeprazole.
  • No evidence of significant drug related safety problems was seen in a study of patients with mild to moderate hepatic impairment versus normal age and sex matched controls. However because there are no clinical data on the use of rabeprazole in the treatment of patients with severe hepatic dysfunction the prescriber is advised to exercise caution when treatment with Rabeprazole 20mg Gastro-resistant. Tablets is first initiated in such patients.
  • Co-administration of atazanavir with Rabeprazole is not recommended.
  • Treatment with proton pump inhibitors, including rabeprazole, may possibly increase the risk of gastrointestinal infections such as Salmonella, Campylobacter and Clostridium difficile.
Hypomagnesaemia: Severe hypomagnesaemia has been reported in patients treated with PPIs like rabeprazole for at least three months, and in most cases for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia can occur but they may begin insidiously and be overlooked. In most affected patients, hypomagnesaemia improved after magnesium replacement and discontinuation of the PPI. For patients expected to be on prolonged treatment or who take PPIs with digoxin or drugs that may cause hypomagnesaemia (e.g., diuretics), health care professionals should consider measuring magnesium levels before starting PPI treatment and periodically during treatment.

Influence on vitamin B12 absorption: Rabeprazole sodium, as all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or a- chlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy or if respective clinical symptoms are observed.

Subacute cutaneous lupus erythematosus (SCLE): Proton pump inhibitors are associated with very infrequent cases of SCLE. If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping Rabeprazole. SCLE after previous treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors.

Interference with laboratory tests: Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Rabeprazole 20mg Gastro-resistant Tablets treatment should be stopped for at least 5 days before CgA measurements. If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of proton pump inhibitor treatment.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

The maximum established exposure has not exceeded 60 mg twice daily, or 160 mg once daily. Effects are  generally minimal, representative of the known adverse event profile and reversible without further medical intervention. No specific antidote is known. Rabeprazole is extensively protein bound and is, therefore, not dialysable. As in any case of overdose, treatment should be symptomatic and general supportive measures should be utilised.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Rabeprazole Sodium

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Acifix Sprinkle Capsule

10 mg

Rabeprazole Sodium

Beximco Pharmaceuticals PLC.

৳ ৩.৪৩ ৳ ৩.৫০ ২% ছাড় প্রতি ইউনিট

Finix Capsule

10 mg

Rabeprazole Sodium

Opsonin Pharma Limited

৳ ৩.৪৩ ৳ ৩.৫ ২% ছাড় প্রতি ইউনিট

Profast Tablet

20 mg

Rabeprazole Sodium

Renata PLC.

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Rabecare Tablet

10 mg

Rabeprazole Sodium

Novelta Bestway Pharmaceuticals Ltd.

৳ ৪.৯২ ৳ ৫.০২ ২% ছাড় প্রতি ইউনিট

Rabeprol Tablet

20 mg

Rabeprazole Sodium

Somatec Pharmaceuticals Ltd.

৳ ৫.৬৪ ৳ ৫.৭৫ ২% ছাড় প্রতি ইউনিট

R-20 Tablet

20 mg

Rabeprazole Sodium

Asiatic Laboratories Ltd.

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

Rabecon Tablet

20 mg

Rabeprazole Sodium

Biopharma Ltd.

৳ ৫.৮৮ ৳ ৬.০০ ২% ছাড় প্রতি ইউনিট

RP-20 Tablet

20 mg

Rabeprazole Sodium

Globe Pharmaceuticals Ltd.

৳ ৬.৭৬ ৳ ৬.৯ ২% ছাড় প্রতি ইউনিট

Acifix Tablet (Enteric Coated)

20 mg

Rabeprazole Sodium

Beximco Pharmaceuticals PLC.

৳ ৬.৮৬ ৳ ৭.০০ ২% ছাড় প্রতি ইউনিট

Acipra Capsule (Enteric Coated)

20 mg

Rabeprazole Sodium

Alco Pharma Ltd.

৳ ৬.৮৬ ৳ ৭.০০ ২% ছাড় প্রতি ইউনিট

সব দেখুন ৪৮ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।